Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel thrombin inhibitor prodrugs for oral administration

Nov. 20, 2000

AstraZeneca presents new P2X7 receptor antagonists and their potential use

Nov. 20, 2000

Triarylimidazoles synthesized at SmithKline Beecham active as inhibitors of TGF-beta signaling

Nov. 20, 2000

Xanthine-based inhibitors of IL-12 signaling patented by Cell Therapeutics

Nov. 20, 2000

Recent patent discloses novel compounds particularly useful for asthma and rhinitis

Nov. 17, 2000

Shionogi's U.S. subsidiary identifies specific antitumor agents with a cyanoguanidine structure

Nov. 17, 2000

Akzo presents new LH receptor agonists and their use in controlling fertility

Nov. 17, 2000

SCRAS issued patent for new series of somatostatin receptor modulators

Nov. 17, 2000

Canadian company presents new HIV integrase inhibitors

Nov. 17, 2000

Research at Pacific leads to identification of potent new antiinflammatory agents

Nov. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...